- 28 Feb 2019
- Cold Call Podcast
Pursuing Precision Medicine at Intermountain Healthcare
What happens when Intermountain Healthcare invests resources in an innovative precision medicine unit to provide life-extending, genetically targeted therapies to late-stage cancer patients? Professors Richard Hamermesh and Kathy Giusti discuss the case and its connections to their work with the Kraft Precision Medicine Accelerator. Open for comment; Comment(s) posted.
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
The Kraft Precision Medicine Accelerator aims to speed up the development and delivery of cancer therapies by improving the business processes that surround them. Open for comment; Comment(s) posted.
- 06 Jan 2016
- Cold Call Podcast
A Microchip in Your Medicine
Digitally-enabled prescription medication may sound futuristic. Thanks to Proteus, the future is now. The company has developed the technology to place microchips inside prescription pills, allowing doctors to retrieve real-time updates on everything from dosing, to vital signs, to the efficacy of different medications. However, regulating and marketing such ground-breaking technology is almost as complicated as the medical conditions it can help cure. Professor Richard Hamermesh unpacks the challenges of changing the world of medicine. Open for comment; Comment(s) posted.
- 05 Nov 2015
- Cold Call Podcast
The Long Run: the Impact of Brain Injuries on the NFL
Today’s NFL is fast-paced and hard-hitting. Though players are well-compensated, many wonder about the long-term cost of those violent collisions on the athletes, the league, and culture at large. Harvard Business School Professor Richard Hamermesh discusses those implications and his case “The National Football League and Brain Injuries” on the latest episode of Cold Call. Open for comment; Comment(s) posted.
- 18 Aug 2014
- Research & Ideas
Have a Better Idea To Improve Health Care?
Harvard launches an open competition to promote already proven innovations that could increase the quality and lower the cost of health care. Closed for comment; 0 Comment(s) posted.
- 05 Dec 2013
- Op-Ed
Encourage Breakthrough Health Care by Competing on Products Rather Than Patents
For too long, the science behind breakthrough therapeutics has been locked behind patents held by universities. Richard Hamermesh proposes the market compete on solutions rather than intellectual property rights. Closed for comment; 0 Comment(s) posted.
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
Perhaps no industry has caught the research attention of Harvard Business School faculty as much as health care. Researchers are investigating business-focused solutions on everything from improving team work among surgical teams to developing market motivations that increase the use of water purification in poor villages. Key concepts include: The $2 trillion American health care system has grown bloated and overly expensive, and it delivers poor service to many patients. Harvard Business School faculty are looking at the system through a business management perspective to recommend changes in almost all aspects of health care research and delivery. Around the world, HBS researchers are studying ways to improve medical services to the poor using techniques that include everything from motivational marketing to microfinance. Closed for comment; 0 Comment(s) posted.
- 22 Apr 2002
- Lessons from the Classroom
Entrepreneurship: It Can Be Taught
Highlights from a discussion with HBS professors Howard Stevenson, Richard Hamermesh, and Paul Marshall (moderated by Mike Roberts) on teaching entrepreneurship at HBS. Closed for comment; 0 Comment(s) posted.
Post-COVID Health Care: More Screens, Less Red Tape?
The coronavirus pandemic might lead to major changes in patient care, physician compensation, and regulation. Experts from Harvard Business School's Health Care Initiative share their predictions. Open for comment; Comment(s) posted.